APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Modulators

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GABA Receptor Modulators Market Analysis and Forecast 2026-2032

Report ID 173993690220 December 2025211 pages

Choose your research edition.

Industry ResearchGABA Receptor Modulators Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Modulators Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal GABA Receptor Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Modulators Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Modulators Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global GABA Receptor Modulators market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for GABA Receptor Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GABA Receptor Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GABA Receptor Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GABA Receptor Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of GABA Receptor Modulators include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sanofi, Novartis, Mylan, Roche and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for GABA Receptor Modulators, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GABA Receptor Modulators, also provides the sales of main regions and countries. Of the upcoming market potential for GABA Receptor Modulators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GABA Receptor Modulators sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GABA Receptor Modulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GABA Receptor Modulators sales, projected growth trends, production technology, application and end-user industry.

GABA Receptor Modulators Segment by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

Sandoz

SAGE Therapeutics

Neurelis

Jazz Pharmaceuicals

Hikma

CHEPLAPHARM

Apotex

Akorn

GABA Receptor Modulators Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

GABA Receptor Modulators Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABA Receptor Modulators Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of GABA Receptor Modulators in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of GABA Receptor Modulators manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GABA Receptor Modulators sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GABA Receptor Modulators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. GABAA Receptors Major Manufacturers Table 3. GABAB Receptors Major Manufacturers Table 4. GABAC Receptors Major Manufacturers Table 5. Global GABA Receptor Modulators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Epilepsy Major Manufacturers Table 7. Anxiety Major Manufacturers Table 8. Neuropathic Pain Major Manufacturers Table 9. Insomnia Major Manufacturers Table 10. Other Major Manufacturers Table 11. GABA Receptor Modulators Industry Trends Table 12. GABA Receptor Modulators Industry Drivers Table 13. GABA Receptor Modulators Industry Opportunities and Challenges Table 14. GABA Receptor Modulators Industry Restraints Table 15. Global GABA Receptor Modulators Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global GABA Receptor Modulators Revenue by Region (2021-2026) & (US$ Million) Table 17. Global GABA Receptor Modulators Revenue by Region (2027-2032) & (US$ Million) Table 18. Global GABA Receptor Modulators Revenue Market Share by Region (2021-2026) Table 19. Global GABA Receptor Modulators Revenue Market Share by Region (2027-2032) Table 20. Global GABA Receptor Modulators Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global GABA Receptor Modulators Sales by Region (2021-2026) & (K Units) Table 22. Global GABA Receptor Modulators Sales by Region (2027-2032) & (K Units) Table 23. Global GABA Receptor Modulators Sales Market Share by Region (2021-2026) Table 24. Global GABA Receptor Modulators Sales Market Share by Region (2027-2032) Table 25. Global GABA Receptor Modulators Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global GABA Receptor Modulators Revenue Market Share by Manufacturers (2021-2026) Table 27. Global GABA Receptor Modulators Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global GABA Receptor Modulators Sales Market Share by Manufacturers (2021-2026) Table 29. Global GABA Receptor Modulators Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global GABA Receptor Modulators Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global GABA Receptor Modulators Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global GABA Receptor Modulators Manufacturers, Product Type & Application Table 33. Global GABA Receptor Modulators Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global GABA Receptor Modulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global GABA Receptor Modulators Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 38. Global GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 39. Global GABA Receptor Modulators Revenue Market Share by Type (2021-2026) Table 40. Global GABA Receptor Modulators Revenue Market Share by Type (2027-2032) Table 41. Global GABA Receptor Modulators Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 43. Global GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 44. Global GABA Receptor Modulators Sales Market Share by Type (2021-2026) Table 45. Global GABA Receptor Modulators Sales Market Share by Type (2027-2032) Table 46. Global GABA Receptor Modulators Price by Type (2021-2026) & (US$/Unit) Table 47. Global GABA Receptor Modulators Price by Type (2027-2032) & (US$/Unit) Table 48. Global GABA Receptor Modulators Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 50. Global GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 51. Global GABA Receptor Modulators Revenue Market Share by Application (2021-2026) Table 52. Global GABA Receptor Modulators Revenue Market Share by Application (2027-2032) Table 53. Global GABA Receptor Modulators Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 55. Global GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 56. Global GABA Receptor Modulators Sales Market Share by Application (2021-2026) Table 57. Global GABA Receptor Modulators Sales Market Share by Application (2027-2032) Table 58. Global GABA Receptor Modulators Price by Application (2021-2026) & (US$/Unit) Table 59. Global GABA Receptor Modulators Price by Application (2027-2032) & (US$/Unit) Table 60. Takeda Company Information Table 61. Takeda Business Overview Table 62. Takeda GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Takeda GABA Receptor Modulators Product Portfolio Table 64. Takeda Recent Development Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Teva GABA Receptor Modulators Product Portfolio Table 69. Teva Recent Development Table 70. Sun Pharma Company Information Table 71. Sun Pharma Business Overview Table 72. Sun Pharma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sun Pharma GABA Receptor Modulators Product Portfolio Table 74. Sun Pharma Recent Development Table 75. Shanghai Pharmaceuticals Holding Company Information Table 76. Shanghai Pharmaceuticals Holding Business Overview Table 77. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio Table 79. Shanghai Pharmaceuticals Holding Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sanofi GABA Receptor Modulators Product Portfolio Table 84. Sanofi Recent Development Table 85. Novartis Company Information Table 86. Novartis Business Overview Table 87. Novartis GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Novartis GABA Receptor Modulators Product Portfolio Table 89. Novartis Recent Development Table 90. Mylan Company Information Table 91. Mylan Business Overview Table 92. Mylan GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Mylan GABA Receptor Modulators Product Portfolio Table 94. Mylan Recent Development Table 95. Roche Company Information Table 96. Roche Business Overview Table 97. Roche GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Roche GABA Receptor Modulators Product Portfolio Table 99. Roche Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Pfizer GABA Receptor Modulators Product Portfolio Table 104. Pfizer Recent Development Table 105. Huazhong Pharmaceutical Company Information Table 106. Huazhong Pharmaceutical Business Overview Table 107. Huazhong Pharmaceutical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio Table 109. Huazhong Pharmaceutical Recent Development Table 110. Sichuan HaiscoPharmaceuical Company Information Table 111. Sichuan HaiscoPharmaceuical Business Overview Table 112. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio Table 114. Sichuan HaiscoPharmaceuical Recent Development Table 115. GSK Company Information Table 116. GSK Business Overview Table 117. GSK GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. GSK GABA Receptor Modulators Product Portfolio Table 119. GSK Recent Development Table 120. Fresenius Kabi Company Information Table 121. Fresenius Kabi Business Overview Table 122. Fresenius Kabi GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Fresenius Kabi GABA Receptor Modulators Product Portfolio Table 124. Fresenius Kabi Recent Development Table 125. Changzhou Siyao Pharmaceutical Company Information Table 126. Changzhou Siyao Pharmaceutical Business Overview Table 127. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio Table 129. Changzhou Siyao Pharmaceutical Recent Development Table 130. AstraZeneca Company Information Table 131. AstraZeneca Business Overview Table 132. AstraZeneca GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. AstraZeneca GABA Receptor Modulators Product Portfolio Table 134. AstraZeneca Recent Development Table 135. WG Critical Care Company Information Table 136. WG Critical Care Business Overview Table 137. WG Critical Care GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. WG Critical Care GABA Receptor Modulators Product Portfolio Table 139. WG Critical Care Recent Development Table 140. Viatris Company Information Table 141. Viatris Business Overview Table 142. Viatris GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Viatris GABA Receptor Modulators Product Portfolio Table 144. Viatris Recent Development Table 145. Torrent Pharma Company Information Table 146. Torrent Pharma Business Overview Table 147. Torrent Pharma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Torrent Pharma GABA Receptor Modulators Product Portfolio Table 149. Torrent Pharma Recent Development Table 150. Sandoz Company Information Table 151. Sandoz Business Overview Table 152. Sandoz GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Sandoz GABA Receptor Modulators Product Portfolio Table 154. Sandoz Recent Development Table 155. SAGE Therapeutics Company Information Table 156. SAGE Therapeutics Business Overview Table 157. SAGE Therapeutics GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. SAGE Therapeutics GABA Receptor Modulators Product Portfolio Table 159. SAGE Therapeutics Recent Development Table 160. Neurelis Company Information Table 161. Neurelis Business Overview Table 162. Neurelis GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Neurelis GABA Receptor Modulators Product Portfolio Table 164. Neurelis Recent Development Table 165. Jazz Pharmaceuicals Company Information Table 166. Jazz Pharmaceuicals Business Overview Table 167. Jazz Pharmaceuicals GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio Table 169. Jazz Pharmaceuicals Recent Development Table 170. Hikma Company Information Table 171. Hikma Business Overview Table 172. Hikma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Hikma GABA Receptor Modulators Product Portfolio Table 174. Hikma Recent Development Table 175. CHEPLAPHARM Company Information Table 176. CHEPLAPHARM Business Overview Table 177. CHEPLAPHARM GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. CHEPLAPHARM GABA Receptor Modulators Product Portfolio Table 179. CHEPLAPHARM Recent Development Table 180. Apotex Company Information Table 181. Apotex Business Overview Table 182. Apotex GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. Apotex GABA Receptor Modulators Product Portfolio Table 184. Apotex Recent Development Table 185. Akorn Company Information Table 186. Akorn Business Overview Table 187. Akorn GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 188. Akorn GABA Receptor Modulators Product Portfolio Table 189. Akorn Recent Development Table 190. North America GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 191. North America GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 192. North America GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 193. North America GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 194. North America GABA Receptor Modulators Sales Price by Type (2021-2026) & (US$/Unit) Table 195. North America GABA Receptor Modulators Sales Price by Type (2027-2032) & (US$/Unit) Table 196. North America GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 197. North America GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 198. North America GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 199. North America GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 200. North America GABA Receptor Modulators Sales Price by Application (2021-2026) & (US$/Unit) Table 201. North America GABA Receptor Modulators Sales Price by Application (2027-2032) & (US$/Unit) Table 202. North America GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. North America GABA Receptor Modulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. North America GABA Receptor Modulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. North America GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. North America GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 207. North America GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 208. North America GABA Receptor Modulators Sales Price by Country (2021-2026) & (US$/Unit) Table 209. North America GABA Receptor Modulators Sales Price by Country (2027-2032) & (US$/Unit) Table 210. United States GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 211. Canada GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 212. Europe GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 213. Europe GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 214. Europe GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 215. Europe GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 216. Europe GABA Receptor Modulators Sales Price by Type (2021-2026) & (US$/Unit) Table 217. Europe GABA Receptor Modulators Sales Price by Type (2027-2032) & (US$/Unit) Table 218. Europe GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 219. Europe GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 220. Europe GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 221. Europe GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 222. Europe GABA Receptor Modulators Sales Price by Application (2021-2026) & (US$/Unit) Table 223. Europe GABA Receptor Modulators Sales Price by Application (2027-2032) & (US$/Unit) Table 224. Europe GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Europe GABA Receptor Modulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Europe GABA Receptor Modulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Europe GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 228. Europe GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 229. Europe GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 230. Europe GABA Receptor Modulators Sales Price by Country (2021-2026) & (US$/Unit) Table 231. Europe GABA Receptor Modulators Sales Price by Country (2027-2032) & (US$/Unit) Table 232. Germany GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 233. France GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 234. U.K. GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 235. Italy GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 236. Netherlands GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 237. China GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 238. China GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 239. China GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 240. China GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 241. China GABA Receptor Modulators Sales Price by Type (2021-2026) & (US$/Unit) Table 242. China GABA Receptor Modulators Sales Price by Type (2027-2032) & (US$/Unit) Table 243. China GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 244. China GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 245. China GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 246. China GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 247. China GABA Receptor Modulators Sales Price by Application (2021-2026) & (US$/Unit) Table 248. China GABA Receptor Modulators Sales Price by Application (2027-2032) & (US$/Unit) Table 249. Asia GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 250. Asia GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 251. Asia GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 252. Asia GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 253. Asia GABA Receptor Modulators Sales Price by Type (2021-2026) & (US$/Unit) Table 254. Asia GABA Receptor Modulators Sales Price by Type (2027-2032) & (US$/Unit) Table 255. Asia GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 256. Asia GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 257. Asia GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 258. Asia GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 259. Asia GABA Receptor Modulators Sales Price by Application (2021-2026) & (US$/Unit) Table 260. Asia GABA Receptor Modulators Sales Price by Application (2027-2032) & (US$/Unit) Table 261. Asia GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. Asia GABA Receptor Modulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. Asia GABA Receptor Modulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. Asia GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 265. Asia GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 266. Asia GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 267. Asia GABA Receptor Modulators Sales Price by Country (2021-2026) & (US$/Unit) Table 268. Asia GABA Receptor Modulators Sales Price by Country (2027-2032) & (US$/Unit) Table 269. Japan GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 270. South Korea GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 271. India GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 272. Australia GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 273. China Taiwan GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 274. Southeast Asia GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 275. SAMEA GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 276. SAMEA GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 277. SAMEA GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 278. SAMEA GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 279. SAMEA GABA Receptor Modulators Sales Price by Type (2021-2026) & (US$/Unit) Table 280. SAMEA GABA Receptor Modulators Sales Price by Type (2027-2032) & (US$/Unit) Table 281. SAMEA GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 282. SAMEA GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 283. SAMEA GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 284. SAMEA GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 285. SAMEA GABA Receptor Modulators Sales Price by Application (2021-2026) & (US$/Unit) Table 286. SAMEA GABA Receptor Modulators Sales Price by Application (2027-2032) & (US$/Unit) Table 287. SAMEA GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 288. SAMEA GABA Receptor Modulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 289. SAMEA GABA Receptor Modulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 290. SAMEA GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 291. SAMEA GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 292. SAMEA GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 293. SAMEA GABA Receptor Modulators Sales Price by Country (2021-2026) & (US$/Unit) Table 294. SAMEA GABA Receptor Modulators Sales Price by Country (2027-2032) & (US$/Unit) Table 295. Brazil GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 296. Argentina GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 297. Chile GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 298. Colombia GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 299. Peru GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 300. Saudi Arabia GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 301. Israel GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 302. UAE GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 303. Turkey GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 304. Iran GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 305. Egypt GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Table 306. Key Raw Materials Table 307. Raw Materials Key Suppliers Table 308. GABA Receptor Modulators Distributors List Table 309. GABA Receptor Modulators Customers List Table 310. Research Programs/Design for This Report Table 311. Authors List of This Report Table 312. Secondary Sources Table 313. Primary Sources List of Figures Figure 1. GABA Receptor Modulators Image Figure 2. Global GABA Receptor Modulators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Modulators Market Size Share 2021 VS 2025 VS 2032 Figure 4. GABAA Receptors Image Figure 5. GABAB Receptors Image Figure 6. GABAC Receptors Image Figure 7. Global GABA Receptor Modulators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global GABA Receptor Modulators Market Size Share 2021 VS 2025 VS 2032 Figure 9. Epilepsy Image Figure 10. Anxiety Image Figure 11. Neuropathic Pain Image Figure 12. Insomnia Image Figure 13. Other Image Figure 14. Global GABA Receptor Modulators Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Figure 16. Global GABA Receptor Modulators Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global GABA Receptor Modulators Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global GABA Receptor Modulators Revenue Market Share by Region (2021-2032) Figure 19. Global GABA Receptor Modulators Sales (2021-2032) & (K Units) Figure 20. Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global GABA Receptor Modulators Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico GABA Receptor Modulators Sales YoY (2021-2032) & (K Units) Figure 23. Europe GABA Receptor Modulators Sales YoY (2021-2032) & (K Units) Figure 24. China GABA Receptor Modulators Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) GABA Receptor Modulators Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa GABA Receptor Modulators Sales YoY (2021-2032) & (K Units) Figure 27. Global GABA Receptor Modulators Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global GABA Receptor Modulators Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global GABA Receptor Modulators Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global GABA Receptor Modulators Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global GABA Receptor Modulators Revenue Market Share by Type (2021-2032) Figure 33. Global GABA Receptor Modulators Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global GABA Receptor Modulators Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global GABA Receptor Modulators Sales Market Share by Type (2021-2032) Figure 36. Global GABA Receptor Modulators Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global GABA Receptor Modulators Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global GABA Receptor Modulators Revenue Market Share by Application (2021-2032) Figure 39. Global GABA Receptor Modulators Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global GABA Receptor Modulators Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global GABA Receptor Modulators Sales Market Share by Application (2021-2032) Figure 42. North America GABA Receptor Modulators Revenue Share by Type (2021-2032) Figure 43. North America GABA Receptor Modulators Sales Share by Type (2021-2032) Figure 44. North America GABA Receptor Modulators Revenue Share by Application (2021-2032) Figure 45. North America GABA Receptor Modulators Sales Share by Application (2021-2032) Figure 46. North America GABA Receptor Modulators Revenue Share by Country (2021-2032) Figure 47. North America GABA Receptor Modulators Sales Share by Country (2021-2032) Figure 48. Europe GABA Receptor Modulators Revenue Share by Type (2021-2032) Figure 49. Europe GABA Receptor Modulators Sales Share by Type (2021-2032) Figure 50. Europe GABA Receptor Modulators Revenue Share by Application (2021-2032) Figure 51. Europe GABA Receptor Modulators Sales Share by Application (2021-2032) Figure 52. Europe GABA Receptor Modulators Revenue Share by Country (2021-2032) Figure 53. Europe GABA Receptor Modulators Sales Share by Country (2021-2032) Figure 54. China GABA Receptor Modulators Revenue Share by Type (2021-2032) Figure 55. China GABA Receptor Modulators Sales Share by Type (2021-2032) Figure 56. China GABA Receptor Modulators Revenue Share by Application (2021-2032) Figure 57. China GABA Receptor Modulators Sales Share by Application (2021-2032) Figure 58. Asia GABA Receptor Modulators Revenue Share by Type (2021-2032) Figure 59. Asia GABA Receptor Modulators Sales Share by Type (2021-2032) Figure 60. Asia GABA Receptor Modulators Revenue Share by Application (2021-2032) Figure 61. Asia GABA Receptor Modulators Sales Share by Application (2021-2032) Figure 62. Asia GABA Receptor Modulators Revenue Share by Country (2021-2032) Figure 63. Asia GABA Receptor Modulators Sales Share by Country (2021-2032) Figure 64. SAMEA GABA Receptor Modulators Revenue Share by Type (2021-2032) Figure 65. SAMEA GABA Receptor Modulators Sales Share by Type (2021-2032) Figure 66. SAMEA GABA Receptor Modulators Revenue Share by Application (2021-2032) Figure 67. SAMEA GABA Receptor Modulators Sales Share by Application (2021-2032) Figure 68. SAMEA GABA Receptor Modulators Revenue Share by Country (2021-2032) Figure 69. SAMEA GABA Receptor Modulators Sales Share by Country (2021-2032) Figure 70. GABA Receptor Modulators Value Chain Figure 71. Manufacturing Cost Structure Figure 72. GABA Receptor Modulators Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • Sandoz
  • SAGE Therapeutics
  • Neurelis
  • Jazz Pharmaceuicals
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GABA Receptor Modulators Market by Type
  3. 1.2.1 Global GABA Receptor Modulators Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 GABAA Receptors
  5. 1.2.3 GABAB Receptors
  6. 1.2.4 GABAC Receptors
  7. 1.3 GABA Receptor Modulators Market by Application
  8. 1.3.1 Global GABA Receptor Modulators Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Epilepsy
  10. 1.3.3 Anxiety
  11. 1.3.4 Neuropathic Pain
  12. 1.3.5 Insomnia
  13. 1.3.6 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 GABA Receptor Modulators Market Dynamics
  1. 2.1 GABA Receptor Modulators Industry Trends
  2. 2.2 GABA Receptor Modulators Industry Drivers
  3. 2.3 GABA Receptor Modulators Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Modulators Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global GABA Receptor Modulators Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global GABA Receptor Modulators Revenue by Region
  3. 3.2.1 Global GABA Receptor Modulators Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GABA Receptor Modulators Revenue by Region (2021-2026)
  5. 3.2.3 Global GABA Receptor Modulators Revenue by Region (2027-2032)
  6. 3.2.4 Global GABA Receptor Modulators Revenue Market Share by Region (2021-2032)
  7. 3.3 Global GABA Receptor Modulators Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global GABA Receptor Modulators Sales by Region
  9. 3.4.1 Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global GABA Receptor Modulators Sales by Region (2021-2026)
  11. 3.4.3 Global GABA Receptor Modulators Sales by Region (2027-2032)
  12. 3.4.4 Global GABA Receptor Modulators Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global GABA Receptor Modulators Revenue by Manufacturers
  2. 4.1.1 Global GABA Receptor Modulators Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global GABA Receptor Modulators Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global GABA Receptor Modulators Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GABA Receptor Modulators Sales by Manufacturers
  6. 4.2.1 Global GABA Receptor Modulators Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global GABA Receptor Modulators Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global GABA Receptor Modulators Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global GABA Receptor Modulators Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global GABA Receptor Modulators Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global GABA Receptor Modulators Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global GABA Receptor Modulators Manufacturers, Product Type & Application
  13. 4.7 Global GABA Receptor Modulators Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global GABA Receptor Modulators Market CR5 and HHI
  16. 4.8.2 2025 GABA Receptor Modulators Tier 1, Tier 2, and Tier 3
5 GABA Receptor Modulators Market by Type
  1. 5.1 Global GABA Receptor Modulators Revenue by Type
  2. 5.1.1 Global GABA Receptor Modulators Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global GABA Receptor Modulators Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global GABA Receptor Modulators Revenue Market Share by Type (2021-2032)
  5. 5.2 Global GABA Receptor Modulators Sales by Type
  6. 5.2.1 Global GABA Receptor Modulators Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GABA Receptor Modulators Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global GABA Receptor Modulators Sales Market Share by Type (2021-2032)
  9. 5.3 Global GABA Receptor Modulators Price by Type
6 GABA Receptor Modulators Market by Application
  1. 6.1 Global GABA Receptor Modulators Revenue by Application
  2. 6.1.1 Global GABA Receptor Modulators Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global GABA Receptor Modulators Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global GABA Receptor Modulators Revenue Market Share by Application (2021-2032)
  5. 6.2 Global GABA Receptor Modulators Sales by Application
  6. 6.2.1 Global GABA Receptor Modulators Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global GABA Receptor Modulators Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global GABA Receptor Modulators Sales Market Share by Application (2021-2032)
  9. 6.3 Global GABA Receptor Modulators Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda GABA Receptor Modulators Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva GABA Receptor Modulators Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sun Pharma
  14. 7.3.1 Sun Pharma Company Information
  15. 7.3.2 Sun Pharma Business Overview
  16. 7.3.3 Sun Pharma GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharma GABA Receptor Modulators Product Portfolio
  18. 7.3.5 Sun Pharma Recent Developments
  19. 7.4 Shanghai Pharmaceuticals Holding
  20. 7.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 7.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 7.4.3 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio
  24. 7.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 7.5 Sanofi
  26. 7.5.1 Sanofi Company Information
  27. 7.5.2 Sanofi Business Overview
  28. 7.5.3 Sanofi GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi GABA Receptor Modulators Product Portfolio
  30. 7.5.5 Sanofi Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis GABA Receptor Modulators Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan GABA Receptor Modulators Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Roche
  44. 7.8.1 Roche Company Information
  45. 7.8.2 Roche Business Overview
  46. 7.8.3 Roche GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche GABA Receptor Modulators Product Portfolio
  48. 7.8.5 Roche Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer GABA Receptor Modulators Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Huazhong Pharmaceutical
  56. 7.10.1 Huazhong Pharmaceutical Company Information
  57. 7.10.2 Huazhong Pharmaceutical Business Overview
  58. 7.10.3 Huazhong Pharmaceutical GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio
  60. 7.10.5 Huazhong Pharmaceutical Recent Developments
  61. 7.11 Sichuan HaiscoPharmaceuical
  62. 7.11.1 Sichuan HaiscoPharmaceuical Company Information
  63. 7.11.2 Sichuan HaiscoPharmaceuical Business Overview
  64. 7.11.3 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio
  66. 7.11.5 Sichuan HaiscoPharmaceuical Recent Developments
  67. 7.12 GSK
  68. 7.12.1 GSK Company Information
  69. 7.12.2 GSK Business Overview
  70. 7.12.3 GSK GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 GSK GABA Receptor Modulators Product Portfolio
  72. 7.12.5 GSK Recent Developments
  73. 7.13 Fresenius Kabi
  74. 7.13.1 Fresenius Kabi Company Information
  75. 7.13.2 Fresenius Kabi Business Overview
  76. 7.13.3 Fresenius Kabi GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Fresenius Kabi GABA Receptor Modulators Product Portfolio
  78. 7.13.5 Fresenius Kabi Recent Developments
  79. 7.14 Changzhou Siyao Pharmaceutical
  80. 7.14.1 Changzhou Siyao Pharmaceutical Company Information
  81. 7.14.2 Changzhou Siyao Pharmaceutical Business Overview
  82. 7.14.3 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio
  84. 7.14.5 Changzhou Siyao Pharmaceutical Recent Developments
  85. 7.15 AstraZeneca
  86. 7.15.1 AstraZeneca Company Information
  87. 7.15.2 AstraZeneca Business Overview
  88. 7.15.3 AstraZeneca GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 AstraZeneca GABA Receptor Modulators Product Portfolio
  90. 7.15.5 AstraZeneca Recent Developments
  91. 7.16 WG Critical Care
  92. 7.16.1 WG Critical Care Company Information
  93. 7.16.2 WG Critical Care Business Overview
  94. 7.16.3 WG Critical Care GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 WG Critical Care GABA Receptor Modulators Product Portfolio
  96. 7.16.5 WG Critical Care Recent Developments
  97. 7.17 Viatris
  98. 7.17.1 Viatris Company Information
  99. 7.17.2 Viatris Business Overview
  100. 7.17.3 Viatris GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Viatris GABA Receptor Modulators Product Portfolio
  102. 7.17.5 Viatris Recent Developments
  103. 7.18 Torrent Pharma
  104. 7.18.1 Torrent Pharma Company Information
  105. 7.18.2 Torrent Pharma Business Overview
  106. 7.18.3 Torrent Pharma GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Torrent Pharma GABA Receptor Modulators Product Portfolio
  108. 7.18.5 Torrent Pharma Recent Developments
  109. 7.19 Sandoz
  110. 7.19.1 Sandoz Company Information
  111. 7.19.2 Sandoz Business Overview
  112. 7.19.3 Sandoz GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Sandoz GABA Receptor Modulators Product Portfolio
  114. 7.19.5 Sandoz Recent Developments
  115. 7.20 SAGE Therapeutics
  116. 7.20.1 SAGE Therapeutics Company Information
  117. 7.20.2 SAGE Therapeutics Business Overview
  118. 7.20.3 SAGE Therapeutics GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 SAGE Therapeutics GABA Receptor Modulators Product Portfolio
  120. 7.20.5 SAGE Therapeutics Recent Developments
  121. 7.21 Neurelis
  122. 7.21.1 Neurelis Company Information
  123. 7.21.2 Neurelis Business Overview
  124. 7.21.3 Neurelis GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Neurelis GABA Receptor Modulators Product Portfolio
  126. 7.21.5 Neurelis Recent Developments
  127. 7.22 Jazz Pharmaceuicals
  128. 7.22.1 Jazz Pharmaceuicals Company Information
  129. 7.22.2 Jazz Pharmaceuicals Business Overview
  130. 7.22.3 Jazz Pharmaceuicals GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio
  132. 7.22.5 Jazz Pharmaceuicals Recent Developments
  133. 7.23 Hikma
  134. 7.23.1 Hikma Company Information
  135. 7.23.2 Hikma Business Overview
  136. 7.23.3 Hikma GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Hikma GABA Receptor Modulators Product Portfolio
  138. 7.23.5 Hikma Recent Developments
  139. 7.24 CHEPLAPHARM
  140. 7.24.1 CHEPLAPHARM Company Information
  141. 7.24.2 CHEPLAPHARM Business Overview
  142. 7.24.3 CHEPLAPHARM GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 CHEPLAPHARM GABA Receptor Modulators Product Portfolio
  144. 7.24.5 CHEPLAPHARM Recent Developments
  145. 7.25 Apotex
  146. 7.25.1 Apotex Company Information
  147. 7.25.2 Apotex Business Overview
  148. 7.25.3 Apotex GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Apotex GABA Receptor Modulators Product Portfolio
  150. 7.25.5 Apotex Recent Developments
  151. 7.26 Akorn
  152. 7.26.1 Akorn Company Information
  153. 7.26.2 Akorn Business Overview
  154. 7.26.3 Akorn GABA Receptor Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Akorn GABA Receptor Modulators Product Portfolio
  156. 7.26.5 Akorn Recent Developments
8 North America
  1. 8.1 North America GABA Receptor Modulators Market Size by Type
  2. 8.1.1 North America GABA Receptor Modulators Revenue by Type (2021-2032)
  3. 8.1.2 North America GABA Receptor Modulators Sales by Type (2021-2032)
  4. 8.1.3 North America GABA Receptor Modulators Price by Type (2021-2032)
  5. 8.2 North America GABA Receptor Modulators Market Size by Application
  6. 8.2.1 North America GABA Receptor Modulators Revenue by Application (2021-2032)
  7. 8.2.2 North America GABA Receptor Modulators Sales by Application (2021-2032)
  8. 8.2.3 North America GABA Receptor Modulators Price by Application (2021-2032)
  9. 8.3 North America GABA Receptor Modulators Market Size by Country
  10. 8.3.1 North America GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America GABA Receptor Modulators Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe GABA Receptor Modulators Market Size by Type
  2. 9.1.1 Europe GABA Receptor Modulators Revenue by Type (2021-2032)
  3. 9.1.2 Europe GABA Receptor Modulators Sales by Type (2021-2032)
  4. 9.1.3 Europe GABA Receptor Modulators Price by Type (2021-2032)
  5. 9.2 Europe GABA Receptor Modulators Market Size by Application
  6. 9.2.1 Europe GABA Receptor Modulators Revenue by Application (2021-2032)
  7. 9.2.2 Europe GABA Receptor Modulators Sales by Application (2021-2032)
  8. 9.2.3 Europe GABA Receptor Modulators Price by Application (2021-2032)
  9. 9.3 Europe GABA Receptor Modulators Market Size by Country
  10. 9.3.1 Europe GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe GABA Receptor Modulators Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China GABA Receptor Modulators Market Size by Type
  2. 10.1.1 China GABA Receptor Modulators Revenue by Type (2021-2032)
  3. 10.1.2 China GABA Receptor Modulators Sales by Type (2021-2032)
  4. 10.1.3 China GABA Receptor Modulators Price by Type (2021-2032)
  5. 10.2 China GABA Receptor Modulators Market Size by Application
  6. 10.2.1 China GABA Receptor Modulators Revenue by Application (2021-2032)
  7. 10.2.2 China GABA Receptor Modulators Sales by Application (2021-2032)
  8. 10.2.3 China GABA Receptor Modulators Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GABA Receptor Modulators Market Size by Type
  2. 11.1.1 Asia GABA Receptor Modulators Revenue by Type (2021-2032)
  3. 11.1.2 Asia GABA Receptor Modulators Sales by Type (2021-2032)
  4. 11.1.3 Asia GABA Receptor Modulators Price by Type (2021-2032)
  5. 11.2 Asia GABA Receptor Modulators Market Size by Application
  6. 11.2.1 Asia GABA Receptor Modulators Revenue by Application (2021-2032)
  7. 11.2.2 Asia GABA Receptor Modulators Sales by Application (2021-2032)
  8. 11.2.3 Asia GABA Receptor Modulators Price by Application (2021-2032)
  9. 11.3 Asia GABA Receptor Modulators Market Size by Country
  10. 11.3.1 Asia GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia GABA Receptor Modulators Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GABA Receptor Modulators Market Size by Type
  2. 12.1.1 SAMEA GABA Receptor Modulators Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA GABA Receptor Modulators Sales by Type (2021-2032)
  4. 12.1.3 SAMEA GABA Receptor Modulators Price by Type (2021-2032)
  5. 12.2 SAMEA GABA Receptor Modulators Market Size by Application
  6. 12.2.1 SAMEA GABA Receptor Modulators Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA GABA Receptor Modulators Sales by Application (2021-2032)
  8. 12.2.3 SAMEA GABA Receptor Modulators Price by Application (2021-2032)
  9. 12.3 SAMEA GABA Receptor Modulators Market Size by Country
  10. 12.3.1 SAMEA GABA Receptor Modulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA GABA Receptor Modulators Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA GABA Receptor Modulators Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 GABA Receptor Modulators Value Chain Analysis
  2. 13.1.1 GABA Receptor Modulators Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 GABA Receptor Modulators Production Mode & Process
  6. 13.2 GABA Receptor Modulators Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 GABA Receptor Modulators Distributors
  9. 13.2.3 GABA Receptor Modulators Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst